Physician profile
Patricia E Chamul
NPI 1619287869
$911.46
in general payments reported to CMS, 2019-2025
15 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.76 · 2022: $72.80 · 2023: $265 · 2024: $317 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $317.07 | 2021-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $133.48 | 2022-2024 | |
| Novo Nordisk INC | $76.30 | 2023-2025 | Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.36 | 2023-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.29 | 2022-2024 | |
| Abbott Laboratories | $47.89 | 2021-2022 | |
| Amgen INC. | $34.13 | 2025 | Krystexxa |
| Abiomed | $30.24 | 2025 | |
| Gilead Sciences, INC. | $30.12 | 2025 | |
| Exact Sciences Corporation | $29.20 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $22.39 | 2025 | Shingrix, Arexvy, Bexsero |
| Sanofi Pasteur INC. | $20.84 | 2023 | |
| Merck Sharp & Dohme LLC | $19.80 | 2025 | Vaxneuvance, Rotateq, Capvaxive |
| Cranial Technologies, INC | $14.97 | 2021 | |
| Dexcom, INC. | $13.38 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Chamul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.